Annual Information Form for the year ended December 31, 2024, which may be accessed on Vertex's SEDAR+ profile at www.sedarplus.ca. The forward-looking statements contained in this Press Release ...

Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

Can generative AI (gen AI) rip things apart and then try to glue it all back together with more insight, more intelligence, more efficiency, and more value? It really depends on what the application ...

Saurabh Gandhi is Business Intelligence Senior Engineering Manager with 18 years of experience in transforming complex data ...

Nonprofit organizations utilizing the latest ezCheckprinting and virtual printer software no longer need be concerned about ...

What is happening today in Washington is a travesty. And the only ones who can prevent it from going further are the people ...

derives from Vertex’ near $1 billion acquisition of Semma in 2019, and has started enrolling patients in a phase 1/2 study in the US. The therapy takes the form of stem cell-derived human ...